India’s opportunity to lead next generation injectable drug innovation
India is rapidly evolving into a global hub for generic injectable drugs, driven by rising disease burden, cost efficient…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
The algorithmic inversion of pharma
The century-old model is cracking
For more than a hundred years, pharma innovation followed a reassuringly stable pattern. A…
India’s upcoming semaglutide boom: A turning point for GLP‑1 drugs, pricing and patient access
With semaglutide’s Indian patent set to expire on March 20, 2026, domestic drugmakers are preparing to enter the GLP‑1 market,…
Invisible but indispensable: Why high purity & premium grade refined Naphthalene is critical to…
India’s rise as the pharmaceutical hub of the World is one of the country’s most consequential industrial stories. It is a journey…
Redrawing the biopharma map: India’s rise in the biosimilars era
For India’s biopharma sector, 2025 stood out as an inflection point. The approval of 146 recombinant biosimilar therapeutic…
You do not need to become someone else to lead
On International Women’s Day, Gopa Gayakar reflects on self-doubt, leadership and why women in pharma must trust their voice to…
How inclusive leadership drives better health outcomes for women
On International Women’s Day, Asawari Sathaye, Director, Communications and Patient Advocacy, OPPI; explains why greater…
To all women in pharma, current and future leaders
On International Women’s Day, Dr Ranjana Pathak reflects on leadership, resilience and the journey of women in pharma
India’s pharma industry trails behind: The digital validation technology gap
India's pharmaceutical industry will not lose its edge because it forgets how to manufacture; it will lose it because it insists…
Glass vs other pharma packaging materials: Safeguarding purity, enhancing trust
In the highly regulated world of pharmaceuticals, packaging is trusted to deliver efficacy, stability, and patient safety. As…
When companies break bad: Directors’ liability under Drugs and Cosmetics Act, 1940
Vineet Unnikrishnan and Sonu Bhasi, Cyril Amarchand Mangaldas; examine the scope of directors’ liability and vicarious…
Procurement lessons from India’s pharma sector
Arjit Agarwal, Principal Consultant, Business Consulting, Nexdigm highlights that as pharma supply chains navigate unprecedented…
Smarter supply chains for a healthier India
Kishan Kumar, MBA Graduate Student, Southern Connecticut State University, US points out that India’s pharma future will be…
The invisible threat: Why packaging inks are the next major recall risk for pharma
Jatin Takkar, Head – Product Safety & Regulatory, Siegwerk India argues for a shift from checkbox compliance to a…
Advanced excipients: India’s gate to high-value drug formulation
Excipients are becoming a strategic lever in India’s move toward high-value, globally competitive drug formulations. Saransh…
What It Takes to Build Pharmaceutical Facilities That Perform from Day One
The pharmaceutical facility landscape has become increasingly complex. Regulatory expectations, operational efficiency,…
Strategic procurement in clinical trials: A digital transformation imperative
Clinical trial procurement is moving from a narrow, transactional "buying" function to a strategic capability that shapes speed,…
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Pharmacy of the world, a name that India has earned through the provision of low-cost, quality generics to patients…
Beyond the ladder: Why sustainable growth needs to be T-shaped and self-driven
If one looks at the organisations that have excelled in their core operating areas and also considered as employers of choice, one…
Pharma trends that will shape 2026: Building a future-ready, patient-centric industry
As we move closer to 2026, the pharmaceutical ecosystem is undergoing a profound transformation driven by digital innovation,…